Evidence map›Paper›PMID 36147570›Full record

ArticleFrontiers in endocrinology2022

Expression patterns of serum MicroRNAs related to endothelial dysfunction in patients with subclinical hypothyroidism.

Xuelin Yao, Ying Wang, Li Wang, Mingfeng Cao, Aifang Chen, Xinhuan Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xuelin YaoShandong Academy of Medical Sciences, Shandong First Medical University, Taian, China.
Ying WangDepartment of Endocrinology, the Second Affiliated Hospital of Shandong First Medical University, Taian, China.
Li WangDepartment of Pharmacy, the Second Affiliated Hospital of Shandong First Medical University, Taian, China.
Mingfeng CaoDepartment of Endocrinology, the Second Affiliated Hospital of Shandong First Medical University, Taian, China.
Aifang ChenUltrasound Department, the Second Affiliated Hospital of Shandong First Medical University, Taian, China.
Xinhuan ZhangDepartment of Endocrinology, the Second Affiliated Hospital of Shandong First Medical University, Taian, China.
Affiliated Hospital of Taishan Medical University · CNShandong First Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Increasing evidence has shown that elevated Thyroid stimulating hormone (TSH) levels are positively correlated with atherosclerosis (ATH) in patients with subclinical hypothyroidism (SCH). Some researchers found that the dysfunction of Endothelial Cells (ECs) in SCH plays an important role in the pathogenesis of ATH in SCH, but the association remains controversial. Objectives: To determine the expression profiles of serum microRNAs critical to the function of Endothelial cells (ECs) may help reanalyze the possible mechanism underlying ATH in SCH and the association between ATH and SCH. Methods: We used qRT-PCR to perform microRNA profiling and analysis in normal control subjects (NC), patients with SCH alone (SCH), patients with SCH and ATH (SCH+ATH), and patients with ATH without SCH (ATH). Results: Both miR-221-3p and miR-222-3p showed a decreasing expression trend between the SCH and SCH+ATH groups. In addition, miR-126-3p and miR-150-5p showed a stepwise decrease from the NC to SCH groups and then to the SCH+ATH or ATH group. miR-21-5p was unregulated in the SCH, SCH+ATH, and ATH groups. Furthermore, elevated levels of miR-21-5p in SCH+ATH group were higher than SCH and ATH group. No differences were found in the levels of miR-150, miR-126, miR-221 and miR-222 between the ATH and the SCH+ATH subjects. Conclusions: miR-21-5p may be involved in the atherosclerosis process in patients with SCH (SCH and SCH+ATH groups). miR-150-5p may be sensitive risk markers for predicting endothelial dysfunction in patients with ATH (ATH and SCH+ATH groups).

Indexed as

AtherosclerosisHypothyroidismMicroRNAsEndothelial CellsHumansThyrotropinMicroRNAsThyrotropinatherosclerosiscirculating microRNAsdifferentially expressed miRNAsendothelial dysfunctionsubclinical hypothyroidism

Identifiers

PMID36147570
PMCPMC9485940
OpenAlexW4294719237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.